Stryker, Johnson & Johnson post dips in 2020 orthopedics sales: 7 device company notes

Alan Condon -   Print  |

Seven notes from device company notes in the past week, including full-year financial reports from Johnson & Johnson and Stryker.

1. Stryker's 2020 net sales dropped 3.6 percent year over year. Full-year orthopedic net sales dipped 5.6 percent and spine sales dropped 9.5 percent compared to the prior year.

2. Medtronic outlined how it develops and retains diverse talent in its "2020 Global Inclusion, Diversity and Equity Report."

3. Johnson & Johnson's orthopedics sales dropped 12.2 percent year over year in 2020, with spine and sports sales decreasing 15.7 percent.

4. Johnson & Johnson CEO Alex Gorsky expects elective surgical volumes to be most affected in the first quarter.

5. The orthopedic implant market is expected to hit $8.97 billion by 2025, according to a report from Fior Markets.

6. Chicago-based Granite Creek Capital Partners invested in Life Spine.

7. The FDA granted clearance for a sacroiliac screw system, developed by Minnesota spine surgeons.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers